<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               <BR>                  WARNING: CARDIOVASCULAR AND GASTROINTESTINAL RISKS<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        <BR>                           WARNING: CARDIOVASCULAR AND GASTROINTESTINAL RISKS<BR>                        <BR>                        <BR>                           See full prescribing information for complete boxed warning<BR>                        <BR>                        <BR>                           Cardiovascular Risk<BR>                        <BR>                        <BR>                           <BR>                              CELEBREX may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal.  All NSAIDs may have a similar risk. This risk may increase with duration of use.  Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk.  (5.1,14.6)<BR>                              <BR>                           <BR>                           <BR>                              CELEBREX is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery. (4, 5.1)<BR>                              <BR>                           <BR>                        <BR>                        <BR>                           Gastrointestinal Risk<BR>                        <BR>                        <BR>                           <BR>                              NSAIDs, including CELEBREX, cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal.  These events can occur at any time during use and without warning symptoms.  Elderly patients are at greater risk for serious gastrointestinal (GI) events.  (5.4)<BR>                              <BR>                           <BR>                        <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     Cardiovascular Risk<BR>                     <BR>                        <BR>                           <BR>                              CELEBREX may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal.  All nonsteroidal anti-inflammatory drugs (NSAIDs) may have a similar risk. This risk may increase with duration of use.  Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk.  (5.1,14.6)<BR>                              <BR>                           <BR>                           <BR>                              CELEBREX is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery. (4, 5.1)<BR>                              <BR>                           <BR>                        <BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     Gastrointestinal Risk<BR>                     <BR>                        <BR>                           <BR>                              NSAIDs, including CELEBREX, cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events. (5.4)<BR>                              <BR>                           <BR>                        <BR>                     <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>